Research Solutions, Inc.: Form 10-Q for the period ended Mar 31, 2017
Filed with the SEC on May 15, 2017 and accepted by EDGAR at May 15, 2017, 20:33 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-01-01 to 2017-03-31 | $8.6m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2016-07-01 to 2017-03-31 | $24.8m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2017-01-01 to 2017-03-31 | $6.9m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months2016-07-01 to 2017-03-31 | $20.0m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2017-01-01 to 2017-03-31 | $1.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2016-07-01 to 2017-03-31 | $4.9m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2017-01-01 to 2017-03-31 | $2.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2016-07-01 to 2017-03-31 | $6.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-01-01 to 2017-03-31 | −$639.1k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2016-07-01 to 2017-03-31 | −$1.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-01-01 to 2017-03-31 | $3.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2016-07-01 to 2017-03-31 | $9.0k | us-gaap:InterestExpense |
| Income tax | 3 months2017-01-01 to 2017-03-31 | $5.5k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2016-07-01 to 2017-03-31 | $28.5k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-01-01 to 2017-03-31 | −$637.5k | us-gaap:NetIncomeLoss |
| Net income | 9 months2016-07-01 to 2017-03-31 | −$1.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-01-01 to 2017-03-31 | −$0.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2016-07-01 to 2017-03-31 | −$0.08 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-01-01 to 2017-03-31 | −$0.03 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2016-07-01 to 2017-03-31 | −$0.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-01-01 to 2017-03-31 | 23,265,939 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2016-07-01 to 2017-03-31 | 23,199,010 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 9 months2016-07-01 to 2017-03-31 | $42.3k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2016-07-01 to 2017-03-31 | $90.3k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-03-31 | $5.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-03-31 | $11.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-03-31 | $12.5m | us-gaap:Assets |
| Current liabilities | At period end2017-03-31 | $7.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-03-31 | $7.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2017-03-31 | $4.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001144204-17-027537. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.